Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2.
| Inventor | Institute |
|---|---|
| Richard Marais | The Institute of Cancer Research |
| SKU: | 153408 |
|---|---|
| Product description: | This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. |
| Alternate name: | RAF1; Raf-1; c-Raf; NS5; CRAF; v-raf-1 murine leukemia viral oncogene homolog 1 |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Synthetic peptide GQRDpSSYpYWEIEAS coupled to glutaraldehyde |
| Cat. #: | 153408 |
|---|---|
| Provenance and Ownership: | The Anti-Phospho-Raf1 (Ser338) [DPR/2/2A/3A] is owned by Cancer Research UK. CancerTools supplies the Anti-Phospho-Raf1 (Ser338) [DPR/2/2A/3A] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-Phospho-Raf1 (Ser338) [DPR/2/2A/3A] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer; Immunology |
| Application: | WB |
| Target: | Raf-1 |
| Reactivity: | Human |
| Clone: | DPR/2/2A/3A |
| Host: | Rat |
| Class: | Monoclonal |
| Target background: | This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Chiloeches et al. 2001. Mol Cell Biol. 21(7):2423-34. PMID: 11259591. S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3. Mason et al. 1999. EMBO J. 18(8):2137-48. PMID: 10205168. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.